Lessons in Blood Cancer: How Far We Have Come CML

Doctors and researchers have been studying cancer for generations. Thanks to pioneers in science and tireless dedication, we have made great strides in diagnosis, treatment, and the quest for cures. But we need to understand where we started to learn how to get where we are headed.
Join us as Jay Yang, MD discusses the history of CML and highlights just how far we’ve come.
Speaker
Jay Yang, MD
Leader of the Hematology Oncology (Hematologic Malignancies) Multidisciplinary Team
Chairperson of the Pharmacy & Therapeutics Committee
Karmanos Cancer Institute
Professor and Director of the Hematology Course
Wayne State University School of Medicine
Detroit, Michigan

[@ayushrathore7452]

Thank you so much for your endeavours. My younger brother recently diagnosed with CML in chronic phase. We took imatinib 400mg once a day since 15 days. Before it the WBC count was around 80-90k but now it was 6700. I’m eagerly searching the web, read articles and clinical trials about the cure. The society is helping me a lot. Also I want to know more about the effectiveness and the risks of CAR-T cell therapy which is recently launched in india and other methods like allogenic stem cell transplant. 🙏🙏🙏